ProCE Banner Activity

Selecting Therapy for AML Without Predictive Biomarkers or Therapeutically Actionable Genomic or Molecular Alterations

Slideset Download
Download these expert-selected slides on treating patients with AML without targetable biomarkers.

Released: December 13, 2021

Expiration: December 12, 2022

No longer available for credit.



Danielle M. Brander

Danielle M. Brander, MD

Medical Instructor
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from

AbbVie Inc.

Bristol Myers Squibb

Genentech, a member of the Roche Group